Literature DB >> 10602063

Use of bone-bonding hydrogel copolymers in bone: an in vitro and in vivo study of expanding PEO-PBT copolymers in goat femora.

R J Sakkers1, R A Dalmeyer, J R de Wijn, C A van Blitterswijk.   

Abstract

Polyactive(R) [polyethylene oxide-polybuthylene terephtalate (PEO-PBT)] refers to a group of copolymers with bone-bonding properties. In reference to these properties, PEO-PBT copolymers are currently being investigated for their possible use in orthopedic surgery and dentistry. PEO-PBT copolymers exhibit hydrogel behavior. When swelling in fluid is prohibited by mechanical confinement, the copolymers exert a swelling pressure on surrounding structures. In the first part of this study, these swelling pressures were measured in vitro. Polymers with different ratios of PEO-PBT exerted a swelling pressure of more than 2 MPa when tested in fluid between the cross-heads of a Hounsfield test-bench. In the second part of the study, the biocompatibility of PEO-PBT 55-45 and the effect of continuous intramedullary pressure of these copolymers on bone was investigated. Large cylinders of dry PEO-PBT 55-45 were implanted with a tight fit in the distal part of goat femora. Preswollen cylinders of PEO-PBT implanted in the opposite femur served as a control. Although it was assumed that the pressure of dry PEO-PBT on the bone would reach more than 2 MPa with press-fit insertion, no immediate hazardous effects of the expanding polymer were noticed within the first days postoperatively. The goats were sacrificed after 3, 9, and 25 weeks. Histological examination showed good implant-bone contact at different follow-up times in the distal femora with the dry implanted implants. The femora in which the preswollen cylinders had been implanted showed a thin layer of soft tissue between the PEO-PBT implant and bone. The swelling pressure exerted by dry press-fit implanted PEO-PBT implants is an important factor in creating a strong interface bond between PEO-PBT and bone. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602063     DOI: 10.1002/(sici)1097-4636(20000305)49:3<312::aid-jbm3>3.0.co;2-e

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  7 in total

1.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

2.  TGF-beta1-enhanced TCP-coated sensate scaffolds can detect bone bonding.

Authors:  J A Szivek; D S Margolis; B K Garrison; E Nelson; R K Vaidyanathan; D W DeYoung
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2005-04       Impact factor: 3.368

3.  A novel biomimetic polymer scaffold design enhances bone ingrowth.

Authors:  Chris P Geffre; David S Margolis; John T Ruth; Donald W DeYoung; Brandi C Tellis; John A Szivek
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

4.  Osteolytic changes around biodegradable cement restrictors in hip surgery.

Authors:  Matthias Erschbamer; Vilijam Zdravkovic; Johannes Erhardt; Christian Öhlschlegel; Karl Grob
Journal:  Acta Orthop       Date:  2016-02-24       Impact factor: 3.717

5.  3D-printed bioactive scaffolds from nanosilicates and PEOT/PBT for bone tissue engineering.

Authors:  James K Carrow; Andrea Di Luca; Alireza Dolatshahi-Pirouz; Lorenzo Moroni; Akhilesh K Gaharwar
Journal:  Regen Biomater       Date:  2018-12-15

Review 6.  Recent advances in synthetic bioelastomers.

Authors:  Rui Shi; Dafu Chen; Quanyong Liu; Yan Wu; Xiaochuan Xu; Liqun Zhang; Wei Tian
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

7.  A Modular Composite Device of Poly(Ethylene Oxide)/Poly(Butylene Terephthalate) (PEOT/PBT) Nanofibers and Gelatin as a Dual Drug Delivery System for Local Therapy of Soft Tissue Tumors.

Authors:  Anna Liguori; Alessandro De Vita; Giulia Rossi; Luisa Stella Dolci; Silvia Panzavolta; Chiara Gualandi; Laura Mercatali; Toni Ibrahim; Maria Letizia Focarete
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.